intranasal glutathione in parkinson's disease Pharmacokinetics and pharmacodynamics of intranasally administered selegiline nanoparticles with improved brain delivery Frontiers | Bilirubin in Parkinson's
Frontiers Bilirubin in Parkinson's disease: pathogenic mechanisms and therapeutic potentials Research progress on intranasal treatment for Parkinson's disease Wen 2024 Neuroprotection Wiley Online Library Glutathione S transferase: A keystone in Parkinson's disease pathogenesis and therapy ScienceDirect Revolutionizing Parkinson's treatment: Harnessing the potential of intranasal nanoemulsions for targeted therapy Drug Delivery and Translational Research Springer Nature Link Full article: Thermosensitive transniosomal in situ gel of hesperetin for intranasal administration: novel approach for Parkinson's therapy
Pay in 4 interest-free payments of $7.30 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11




